Sign in to view content

Baseline DR Severity and Time to DME Resolution in Patients Treated With Ranibizumab in the RIDE and RISE Clinical Trials

Katherine E Talcott, MD

Video
Published 2021

Related

Diabetic Retinopathy Progression in the Absence of Therapy: An Analysis of Untreated Fellow Eyes in RIDE and RISE
Sophie Jane Bakri, MD
Annual Meeting Talks
2019
National Cohort Study on New Oral Hypoglycemic Agents in Diabetic Retinopathy Progression
Ehsan Rahimy, MD
Annual Meeting Talks
2023
High-Dose Anti-VEGF: Cross-Trial Analysis of Different Doses and Antagonists for the Treatment of Diabetic Macular Edema
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more